Thomas Kissel
Impact in
- Pharmaceutical Science top 0.01%
- Advanced Drug Delivery Systems
- Biomaterials top 0.02%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Advanced Drug Delivery Systems 78
- Biomaterials 95
- biodegradable polymer synthesis and properties 47
- Nanoparticle-Based Drug Delivery 40
- Co-authors
- Dagmar FischerYouxin LiShirui MaoOlivia M. MerkelThomas MerdanBarbara AhlemeyerJosef KrieglsteinHolger Petersen
- Journals
- Journal of Controlled Release (61 papers)Pharmaceutical Research (30 papers)European Journal of Pharmaceutics and Biopharmaceutics (29 papers)International Journal of Pharmaceutics (20 papers)Bioconjugate Chemistry (18 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Kissel
309 papers receiving 26.1k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Pharmaceutical Science 5.8k
- Biomaterials 8.6k
- Molecular Medicine 1.3k
- Surfaces, Coatings and Films 1.8k
- Molecular Biology 12.8k
Countries citing papers authored by Thomas Kissel
This map shows the geographic impact of Thomas Kissel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kissel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kissel more than expected).
Fields of papers citing papers by Thomas Kissel
This network shows the impact of papers produced by Thomas Kissel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kissel. The network helps show where Thomas Kissel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Kissel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 34 | |
| 2 | 2014 | 104 | |
| 3 | 2012 | 6 | |
| 4 | 2010 | 75 | |
| 5 | 2010 | 30 | |
| 6 | 2009 | 51 | |
| 7 | 2008 | 35 | |
| 8 | 2007 | 15 | |
| 9 | 2006 | 54 | |
| 10 | 2006 | 101 | |
| 11 | 2005 | 2 | |
| 12 | 2005 | 33 | |
| 13 | 2004 | 57 | |
| 14 | 2003 | 72 | |
| 15 | 2003 | 24 | |
| 16 | Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Hit paper breakdown → | 2002 | 644 |
| 17 | Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymers | 1999 | 1 |
| 18 | 1996 | 31 | |
| 19 | In vivo biocompatibility study of ABA copolymers | 1995 | 2 |
| 20 | 1995 | 47 |
About Thomas Kissel
Thomas Kissel is a scholar working on Pharmaceutical Science, Biomaterials, Surfaces, Coatings and Films, Polymers and Plastics and Molecular Medicine, having authored 309 papers that have together received 26.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (121 papers), Advanced Drug Delivery Systems (78 papers), Advanced biosensing and bioanalysis techniques (77 papers), biodegradable polymer synthesis and properties (47 papers), Nanoparticle-Based Drug Delivery (40 papers), Inhalation and Respiratory Drug Delivery (33 papers), Virus-based gene therapy research (30 papers) and Dendrimers and Hyperbranched Polymers (24 papers). The work is most often cited by research in Pharmaceutical Science (5.8k citations), Biomaterials (8.6k citations), Molecular Medicine (1.3k citations), Surfaces, Coatings and Films (1.8k citations) and Molecular Biology (12.8k citations). Thomas Kissel has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dagmar Fischer, Youxin Li, Shirui Mao, Olivia M. Merkel, Thomas Merdan, Barbara Ahlemeyer, Josef Krieglstein, Holger Petersen, Michael Neu and Udo Bakowsky. Their work appears in journals such as Journal of Controlled Release, Pharmaceutical Research, European Journal of Pharmaceutics and Biopharmaceutics, International Journal of Pharmaceutics and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.